Comparison of Three-Dimensional Choroidal Contour in Patients With Neovascular Age-Related Macular Degeneration and Their Fellow Eyes. [PDF]
Singh SR +11 more
europepmc +1 more source
Faricimab treat-and-extend approach for neovascular age-related macular degeneration: insights from real-world clinical practice. [PDF]
Ruiz-Medrano J +5 more
europepmc +1 more source
High-Dose 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration: Who Is Being Treated with This New Agent? [PDF]
Liesenhoff C +10 more
europepmc +1 more source
Comparison of Neovascular Age-Related Macular Degeneration Outcomes in Established vs New Patients of a Retina Practice. [PDF]
Du J +10 more
europepmc +1 more source
A systematic review on the effect of bevacizumab in exudative age-related macular degeneration [PDF]
core +1 more source
Correction to "Peptide-Bound Aflibercept Eye Drops for Treatment of Neovascular Age-Related Macular Degeneration in Nonhuman Primates". [PDF]
europepmc +1 more source
Navigating the Decision to Discontinue Intravitreal Injection Therapy in End-Stage Neovascular Age-Related Macular Degeneration. [PDF]
Bennie J, Ramsey DJ.
europepmc +1 more source
Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration: XTEND at 3 Years.
Korobelnik JF +8 more
europepmc +1 more source
Evaluation of the Correlation of Reading Ability and Fixation Status in Patients With Neovascular Age-Related Macular Degeneration. [PDF]
Miki R, Shiba T, Oshitari T, Usui T.
europepmc +1 more source
Faricimab for Refractory Neovascular Age-Related Macular Degeneration: Retrospective Real-World Evidence from India. [PDF]
Biswas RK +7 more
europepmc +1 more source

